These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 7498215

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Clinical, adrenergic and heart endocrine measures in chronic atrial fibrillation as predictors of conversion and maintenance of sinus rhythm after direct current cardioversion.
    Theodorakis GN, Markianos M, Kouroubetsis CK, Livanis EG, Paraskevaidis IA, Kremastinos DT.
    Eur Heart J; 1996 Apr; 17(4):550-6. PubMed ID: 8733088
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Atrial natriuretic peptide level after cardioversion of chronic atrial fibrillation.
    Wozakowska-Kaplon B, Opolski G.
    Int J Cardiol; 2002 May; 83(2):159-65. PubMed ID: 12007688
    [Abstract] [Full Text] [Related]

  • 5. The effects of left ventricular diastolic function on natriuretic peptide levels after cardioversion of atrial fibrillation.
    Bakowski D, Wozakowska-Kapłon B, Opolski G.
    Kardiol Pol; 2009 Apr; 67(4):361-7. PubMed ID: 19492248
    [Abstract] [Full Text] [Related]

  • 6. [Values of atrial natriuretic peptide (ANP) and cyclic guanosine monophosphate (cGMP) in cardioversion].
    Lechleitner P, Genser N, Hauptlorenz S, Putensen C, Mitterschiffthaler G, Artner-Dworzak E, Puschendorf B, Dienstl F.
    Z Kardiol; 1991 Sep; 80(9):574-9. PubMed ID: 1661054
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Atrial natriuretic peptide response to cardioversion of atrial flutter and fibrillation and role of associated heart failure.
    Mookherjee S, Anderson G, Smulyan H, Vardan S.
    Am J Cardiol; 1991 Feb 15; 67(5):377-80. PubMed ID: 1825258
    [Abstract] [Full Text] [Related]

  • 9. Time course for recovery of atrial mechanical and endocrine function post DC cardioversion for persistent atrial fibrillation.
    Thomas MD, Kalra PR, Jones A, Struthers AD, More RS.
    Int J Cardiol; 2005 Jul 20; 102(3):487-91. PubMed ID: 16004895
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Plasma atrial natriuretic peptide response to direct current cardioversion of atrial fibrillation in patients with mitral stenosis.
    Fujiwara H, Ishikura F, Nagata S, Beppu S, Miyatake K.
    J Am Coll Cardiol; 1993 Aug 20; 22(2):575-80. PubMed ID: 8335832
    [Abstract] [Full Text] [Related]

  • 12. Plasma atrial natriuretic peptide levels for predicting the outcome of atrial fibrillation.
    Arad M, Shotan A, Weinberger A, Aurbach I, Rabinowitz B.
    Cardiology; 2001 Aug 20; 95(2):74-9. PubMed ID: 11423710
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Plasma cardiac natriuretic peptides as biochemical markers of recurrence of atrial fibrillation in patients with mild congestive heart failure.
    Mabuchi N, Tsutamoto T, Maeda K, Kinoshita M.
    Jpn Circ J; 2000 Oct 20; 64(10):765-71. PubMed ID: 11059617
    [Abstract] [Full Text] [Related]

  • 15. The dubious value of echocardiographic and plasma ANP measurements in predicting outcome of cardioversion in patients with persistent atrial fibrillation.
    Wozakowska-Kapłon B, Opolski G.
    Int J Cardiol; 2005 Sep 01; 103(3):280-5. PubMed ID: 16098390
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. ANP and BNP in atrial fibrillation before and after cardioversion--and their relationship to cardiac volume and function.
    Therkelsen SK, Groenning BA, Kjaer A, Svendsen JH, Boje Jensen G.
    Int J Cardiol; 2008 Jul 21; 127(3):396-9. PubMed ID: 17628724
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [The influence of electrical cardioversion on left ventricular systolic function, left atrial size, ANP levels and enzymatic activity of CPK and CD-MB in serum of patients with paroxysmal atrial fibrillation].
    Spring A, Kosmala W, Mysiak A.
    Przegl Lek; 1997 Jul 21; 54(9):585-90. PubMed ID: 9501676
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.